Professional
Added to YB: 2025-05-12
Pitch date: 2025-03-31
ILMN [bullish]
Illumina, Inc.
+69.65%
current return
Author Info
No bio for this author
Company Info
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
Market Cap
$18.4B
Pitch Price
$79.50
Price Target
N/A
Dividend
N/A
EV/EBITDA
15.81
P/E
27.05
EV/Sales
4.60
Sector
Life Sciences Tools and Services
Category
growth
Diamond Hill Mid Cap Strategy New Position: Illumina, Inc.
ILMN (new position): 80% market share in genetic sequencing with strong fundamentals & healthy balance sheet. LT growth from cancer screening tests using their products. Stock pressured by weak demand, China concerns, Roche competition & NIH funding cut fears - creating entry opportunity into quality business.
Read full article (1 min)